Bausch + Lomb Corporation a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. a privately held ophthalmic medical device company, today announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus. AcuFocus has delivered breakthrough small aperture intraocular technology to address the diverse unmet needs in eye care, including the IC-8® Apthera&t

Western Dental & Orthodontics, a member of the Sonrava Health family of wellness companies, today announced the opening of a new office in Oroville, California on January 16. The new 4,290-square-foot office is located at 491 Oro Dam Boulevard, at the intersection of Feather River Boulevard, just minutes from major retailers like Walmart, Starbucks, Harbor Freight Tools, and CVS. Equipped with state-of-the-art technology, and supported by experienced dental providers and special

Charles River Laboratories International, Inc. today announced the launch of their new CliniPrimeTM suite of Good Manufacturing Practice (GMP)-compliant cellular starting materials. CliniPrime products provide rapid access to starting materials for cell, and gene-modified cell therapies with a standardized production process for high-quality GMP-compliant products. All CliniPrime products meet the essential regulatory guidelines for clinical trial development and the commercial manufacturing

Driven by the Covid-19 pandemic, the market for point-of-care testing is seen to double in size compared to pre-pandemic levels. In this burgeoning field, multiplexing is the key technology differentiator. Increasing the number of simultaneous assays helps to identify the right biomarker, and thus reduces the cost and time it takes to quell any potential outbreak. ALiA BioTech group took on this challenge 10 years ago and is now ready to deploy a next-generation rapid diagnostic platform that

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announces the launch of the Viz TM Vascular Suite , a AI-powered software enabling vascular care teams to automatically detect and prioritize care for suspected pulmonary embolism, right heart overload, aortic dissection and abdominal aortic aneurysm (AAA). 1 Viz.ai has submitted a new 510(k) application to the US Food and Drug Administration (FDA) for the AAA algorithm. “Recognizing th

Hoag Memorial Hospital Presbyterian recently became the first hospital in Southern California and one of only a handful of hospitals in the world to provide patients with access to a clinical trial that is poised to change the face of cancer treatment. Hoag launched a phase 1 clinical trial to test the efficacy of Actinium-225 DOTATATE in treating recurrent neuroendocrine cancers. Actinium-225 DOTATATE is a new molecular therapy agent that works by targeting molecules on the surface

Cardiovascular Systems, Inc.a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the company has initiated the KAIZEN clinical study of its Diamondback 360© Peripheral Orbital Atherectomy System  for the treatment of calcified plaque in patients with peripheral artery disease. The study is intended to support regulatory approval in Japan. The first KAIZE

Canopy Health is pleased to announce the addition of St. Rose Hospital to its network alliance effective January 1, 2023. St. Rose Hospital has been serving the health care needs of the Hayward area for almost sixty years and is recognized for its leading-edge cardiology services, including being a designated STEMI (heart attack) Receiving Center by Alameda County. "St. Rose Hospital is a great addition to our strong network of hospitals throughout the Bay Area which includes UCSF Health

Traditional Chinese Medicine has been playing an important role in China 's fight against COVID-19. As China shifts the focus of its response to COVID-19 from preventing infections to protecting people's health and preventing serious cases, health authorities are further leveraging the unique strength of traditional Chinese medicine to protect life and people's health. On January 5, China issued the 10th version of the COVID-19 diagnosis and treatment protocol,

LeanTaaS, Inc., a Silicon Valley-based leading provider of AI-powered and SaaS-based capacity management and patient flow software for health systems, today announced it has acquired Hospital IQ, a leading provider of intelligent automation solutions for hospitals. The acquisition values the combined company at more than $1 billion in enterprise value and enables it to power intelligent operations across more than 180+ U.S. health systems. Together, LeanTaaS and Hospital IQ will drive improve